Initial assessment of positron emission tomography for detection of nonpalpable regional lymphatic metastases in melanoma

Journal of Surgical Oncology

Volumn 64, Issue 3, 1997, Pages 181-189

  Wagner, Jeffrey D ^a,c   Schauwecker, Donald ^b   Hutchins, Gary ^b   Coleman III, John J ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INDIANA UNIVERSITY   (United States)

^c 471 Cancer Pavillion Bldg ^*  (United States)

Author keywords

diagnostic imaging; lymph nodes; lymphadenectomy; nuclear medicine; surgery

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; LYMPHADENECTOMY; LYMPHOSCINTIGRAPHY; MALE; MELANOMA; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSPECTIVE STUDY;

ADULT; DEOXYGLUCOSE; FEASIBILITY STUDIES; FEMALE; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MELANOMA; PILOT PROJECTS; PROSPECTIVE STUDIES; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0031006503     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9098(199703)64:3<181::AID-JSO2>3.0.CO;2-6     Document Type: Article

References (30)

1. International Agency for Research on Cancer: "Cancer incidence in five continents." Vol. V. IARC Publ. No. 88. Lyon: IARC, 1987.
2. Beahrs OH, Hedson DE, Hutter RVP, Kennedy BJ (eds): "American Joint Committee on Cancer manual for staging of cancer." 4th ed. Philadelphia: JB Lippincott, 1992.
3. Balch CM, Soong SJ, Murad TM, et al: A multifactorial analysis of melanoma: prognostic factors in patients with stage I, localized melanoma. Surgery 1979;86:343-351.
4. Karakousis CP, Stahl L, Moore R, Holyoke ED: Lymph node dissection in malignant melanoma. J Surg Oncol 1980;13:245-252.
5. Urist NM, Maddox WA, Kennedy JE, Balch CM: Patient risk factors and surgical morbidity after regional lymphadenectomy in 204 melanoma patients. Cancer 1983;51:2152-2156.
6. Reintgen DS, Cox EB, McCarty KS Jr, et al: Efficacy of elective lymph node dissection in patients with intermediate thickness primary melanoma. Ann Surg 1983;198:379-385.
7. Milton GW, Shaw HM, McCarthy WH, et al: Prophylactic lymph node dissection in clinical stage I cutaneous malignant melanoma: results of surgical treatment of 319 patients. Br J Surg 1982;196: 677-684.
8. Balch CM, Soong SJ, Milton GW, et al: A comparison of prognostic factors and surgical results in 1786 patients with localized (stage I) melanoma treated in Alabama, USA, and New South Wales, Australia. Ann Surg 1982;196:677-684.
9. Morton DL, Wanek L, Nizze JA, et al: Improved long term survival after lymphadenectomy of melanoma metastatic to regional nodes: an analysis of prognostic factors in 1134 patients from the John Wayne Cancer Clinic. Ann Surg 1991;214:491-499.
10. Wahl RL, Cody R, Hutchins GD, Mudgett E: Primary and metastatic breast carcinoma: initial clinical evaluation with PET with radiolabeled glucose analog 2-(F18)-fluoro-2-deoxy-D-glucose. Radiology 1991;179:765-770.
11. Harney JB, Wahl RL, Liebert M, et al: Uptake of 2-deoxy-2-(18F)-fluoro-D-glucose in bladder cancer: animal localization and initial patient positron emission tomography. J Urol 1991;145: 279-283.
12. Wahl RL, Harney JB, Hutchins G, Grossman HB: Imaging of renal cancer using positron emission tomography with 2-deoxy-2-(18F)-D-glucose: pilot animal and human studies. J Urol 1991; 146:1470-1474.
13. Brown R, Fisher SJ, Wahl RL: Autoradiographic evaluation of the intratumoral distribution of 2-deoxy-D-glucose and monoclonal antibodies in xenografts of human ovarian adenocarcinoma. J Nucl Med 1993;34:75-82.
14. Wahl RL, Hutchins GD, Buchsbaum DJ: Fluorine-18-2-deoxy-2-fluoro-D-glucose (FDG) uptake into human tumor xenografts: feasibility studies for cancer imaging with PET. Cancer 1991;67: 1544-1549.
15. Som P, Atkins HL, Bandoypadhyay D, et al: A fluorinated glucose analog, 2-fluoro-2-deoxy-D-glucose (F18): nontoxic tracer for rapid tumor detection. J Nucl Med 1980;21:670-675.
16. Kern KA: EMD deoxyglucose uptake imaging in malignant melanoma. J Surg Res 1991;50:643-647.
17. Gritters LS, Francis IR, Zasadny KR, Wahl RL: Initial assessment of positron emission tomography using 2-fluorine-18-fluoro-2-deoxy-D-glucose in the imaging of malignant melanoma. J Nucl Med 1993;34:1420-1426.
18. Steinert HC, Boni RA, Buch A, et al: Malignant melanoma: staging with whold body positron emission tomography and 2-(F18)-fluoro-2-deoxy-D-glucose. Radiology 1995;195:705-709.
19. Boni R, Boni RA, Steinert H, et al: Staging of metastatic melanoma by whole body positron emission tomography using 2-fluorine-18-fluoro-2-deoxy-D-glucose. Br J Dermatol 1995;132:556-562.
20. Balch CM: The role of elective lymph node dissection in melanoma: rationale, results, and controversies. J Clin Oncol 1988;6: 163-172.
21. McCarthy WH, Shaw H, Milton GW: Efficacy of elective lymph node dissection in 2,347 patients with clinical stage I malignant melanoma. Surg Gynecol Obstet 1985;161:575-580.
22. Drepper H, Kohler CO, Bastain B, et al: Benefit of elective lymph node dissection in subgroups of melanoma patients: results of a multicenter study. Cancer 1993;72:741-749.
23. Slingluff CL, Stidham KR, Ricci WM, et al: Surgical management of regional lymph nodes in patients with melanoma: experience with 4,682 patients. Ann Surg 1994;219:120-130.
24. Sim FH, Taylor WF, Pritchard DJ, Soule EH: Lymphadenectomy in the management of state I malignant melanoma: a prospective, randomized study. Mayo Clin Proc 1986;61:697-705.
25. Veronesi U, Adamus J, Bandiera DC, et al: Stage I melanoma of the limbs. Immediate versus delayed node dissection. Tumori 1980;66:392-399.
26. Morton DL, Wen DR, Wong JH, et al: Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992;127:392-399.
27. Morton DL, Wen DR, Foshag LJ, et al: Intraoperative lymphatic mapping and selective cervical lymphadenectomy for early stage melanoma of the head and neck. J Clin Oncol 1993;11:1751-1756.
28. Khansur T, Sanders J, Das S: Evaluation of staging workup in malignant melanoma. Arch Surg 1989;124:847-849.
29. Ardizzoni A, Grimaldi A, Repetto L, et al: Stage I-II melanoma the value of metastatic workup. Oncology 1987;44:87-89.
30. Buzaid AC, Tinoco L, Ross MI, et al: Role of computed tomography in the staging of patients with local-regional metastases of melanoma. J Clin Oncol 1995;13:2104-2108.